News

The Dell Children’s Comprehensive Pediatric Epilepsy Center is hosting its third Innovative Minds: Pediatric Research in Epilepsy Surgery (IMPRES) Conference in collaboration with the Lurie Children’s Epilepsy Center from Friday, June 26, to Sunday, June 28, 2026, at Hotel Van Zandt in downtown Austin. Register now by scanning or clicking… read more 

Congratulations to our faculty members on their new positions! Greg Fonzo, associate professor with tenure, Department of Psychiatry and Behavioral Sciences Esther Melamed, associate professor with tenure, Department of Neurology  

Greg Fonzo and his team were recognized by the Brain and Behavior Research Foundation as a 2025 Leading Research Achievement for their pilot study on noninvasive focused ultrasound neuromodulation therapy as a treatment for mood, anxiety, and trauma-related disorders. The team “observed a significant reduction in a general measure of… read more 

The Texas Department of State Health Services has announced continued funding through August 2027 for the evidence-based Interprofessional Curriculum Approach to Alzheimer’s and Other Dementias project. This $1.45 million initiative is designed to strengthen dementia care training for future healthcare providers over four years (FY24-FY27). Led by principal investigators Jung… read more 

Work by Mulva husband-and-wife researchers MacKenzie Howard, PhD, an assistant professor of neurology and neuroscience, and Audrey Brumback, MD, PhD, an assistant professor of neurology, focuses on understanding neurodevelopmental disorders at the cellular and molecular levels. By defining how different brain circuits process information and how that information processing is altered… read more 

On January 21, The University of Texas at Austin celebrated the Seventh Annual Faculty Authors Reception, an event dedicated to honoring faculty members who published books in 2025. Among this year’s authors included Mulva Clinic faculty member William J. Schwartz, MD. His book, On the Essential Principles and Practice of… read more 

Gliomas are the most common type of pediatric brain tumor, and median survival for children with high-grade gliomas is only one to two years. Due to the paucity of research on pediatric gliomas, most therapies are based on adults and have limited efficacy. Recent studies of pediatric microglia have demonstrated… read more